In a different line of research, Dr. Nitin Joshi and colleagues [76] used PLGA to ferry siRNA across an intact BBB, reducing tau protein levels by 50% in mice, a strategy with potential for AD therapy. This evidence concerns the gene MAPT and Alzheimer disease.